Mitigating antibacterial resistance involves a multifaceted approach. This includes the prudent use of antibiotics, development of new antibacterial agents, and implementation of stewardship programs. Toxicologists contribute by researching alternative therapies, such as phage therapy and antimicrobial peptides, which may offer new avenues for treatment without contributing to resistance.
